Insider trading

Period: 120 months Stock: SRRK Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

57 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

57 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

57 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

57 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
57 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
57 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

57 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
16 Apr 2026
Vaishnaw Akshay President of R&D
Sold at will
$607.09K 12,246 at 49.57
1.9%
Not planned
16 Apr 2026
Woods Keith Chief Operating Officer
Sold at will
$506.65K 10,220 at 49.57
1.6%
Not planned
23 Feb 2026
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold on a plan 3×
$399.35K 8,484 at 47.07
7.9%
Planned (10b5-1)
17 Feb 2026
Ho Junlin GENERAL COUNSEL
Sold at will
$445.74K 9,580 at 46.53
3.8%
Not planned
17 Feb 2026
Sold at will
$420.38K 9,035 at 46.53
5.1%
Not planned
17 Feb 2026
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold at will
$371.71K 7,989 at 46.53
7.0%
Not planned
17 Feb 2026
Marantz Jing L. CHIEF MEDICAL OFFICER
Sold at will
$193.42K 4,157 at 46.53
3.2%
Not planned
22 Jan 2026
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold on a plan 2×
$695.94K 14,898 at 46.71
14.8%
Planned (10b5-1)
16 Jan 2026
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold at will
$373.88K 8,406 at 44.48
7.7%
Not planned
16 Jan 2026
Ho Junlin GENERAL COUNSEL
Sold at will
$356.53K 8,016 at 44.48
3.6%
Not planned
16 Jan 2026
Sold at will
$293.55K 6,600 at 44.48
4.2%
Not planned
16 Jan 2026
Marantz Jing L. CHIEF MEDICAL OFFICER
Sold at will
$257.88K 5,798 at 44.48
5.7%
Not planned
14 Jan 2026
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold on a plan
$592.61K 13,112 at 45.20
10.7%
Planned (10b5-1)
13 Jan 2026
Vaishnaw Akshay President of R&D
Sold at will
$872.70K 20,438 at 42.70
3.3%
Not planned
13 Jan 2026
Woods Keith Chief Operating Officer
Sold at will
$715.05K 16,746 at 42.70
2.8%
Not planned
4 Dec 2025
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold on a plan
$6.17M 136,462 at 45.21
55.6%
Sold half or more
22 Sep 2025
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold at will
$102.85K 3,353 at 30.67
3.0%
Not planned
16 Sep 2025
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold at will
$106.53K 3,178 at 33.52
2.8%
Not planned
18 Aug 2025
Sold at will
$67.88K 2,178 at 31.17
1.4%
Not planned
8 Jul 2025
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold on a plan
$828.90K 24,066 at 34.44
17.2%
Planned (10b5-1)
16 Jun 2025
Ho Junlin GENERAL COUNSEL
Sold at will
$238.15K 7,442 at 32.00
3.2%
Not planned
16 Jun 2025
Sold at will
$197.96K 6,186 at 32.00
3.8%
Not planned
16 Jun 2025
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold at will
$117.38K 3,668 at 32.00
2.6%
Not planned
29 May 2025
Vaishnaw Akshay President of R&D
Sold on a plan 2×
$200.61K 6,750 at 29.72
1.1%
Planned (10b5-1)
25 Apr 2025
Sacco Tracey Chief Commercial Officer
Sold on a plan 2×
$164.13K 5,000 at 32.83
6.5%
Planned (10b5-1)
24 Mar 2025
Moore Erin Interim PFO and PAO
Sold on a plan
$449.24K 13,564 at 33.12
14.1%
Planned (10b5-1)
24 Mar 2025
Sacco Tracey Chief Commercial Officer
Sold on a plan 2×
$215.01K 6,500 at 33.08
8.3%
Planned (10b5-1)
19 Feb 2025
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold on a plan 3×
$2.56M 68,510 at 37.40
38.1%
Planned (10b5-1)
18 Feb 2025
Ho Junlin GENERAL COUNSEL
Sold at will
$211.47K 5,742 at 36.83
2.9%
Not planned
18 Feb 2025
Sold at will
$195.05K 5,296 at 36.83
3.6%
Not planned
18 Feb 2025
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold on a plan
$152.29K 4,135 at 36.83
3.1%
Planned (10b5-1)
16 Jan 2025
Ho Junlin GENERAL COUNSEL
Sold at will
$399.50K 9,039 at 44.20
4.4%
Not planned
16 Jan 2025
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold at will
$324.72K 7,347 at 44.20
5.1%
Not planned
16 Jan 2025
Sold at will
$284.36K 6,434 at 44.20
4.2%
Not planned
16 Jan 2025
Marantz Jing L. CHIEF MEDICAL OFFICER
Sold at will
$249.94K 5,655 at 44.20
7.8%
Not planned
16 Jan 2025
Sacco Tracey Chief Commercial Officer
Sold at will
$171.93K 3,890 at 44.20
7.9%
Not planned
25 Nov 2024
Marantz Jing L. CHIEF MEDICAL OFFICER
Sold on a plan 4×
$251.40K 6,375 at 39.44
8.0%
Planned (10b5-1)
22 Nov 2024
Marantz Jing L. CHIEF MEDICAL OFFICER
Sold on a plan
$64.37K 2,145 at 30.01
2.9%
Planned (10b5-1)
11 Nov 2024
Marantz Jing L. CHIEF MEDICAL OFFICER
Sold on a plan
$63.16K 2,105 at 30.00
2.8%
Planned (10b5-1)
7 Oct 2024
Marantz Jing L. CHIEF MEDICAL OFFICER
Sold on a plan 3×
$2.98M 109,375 at 27.21
60.0%
Sold half or more
7 Oct 2024
Sacco Tracey CHIEF COMMERCIAL OFFICER
Sold on a plan 2×
$768.68K 30,000 at 25.62
37.8%
Planned (10b5-1)
16 Sep 2024
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold at will
$16.61K 1,936 at 8.58
1.3%
Not planned
16 Aug 2024
Sold at will
$13.54K 1,451 at 9.33
0.9%
Not planned
17 Jun 2024
Ho Junlin GENERAL COUNSEL
Sold at will
$42.18K 4,695 at 8.98
2.2%
Not planned
17 Jun 2024
Sold at will
$38.68K 4,305 at 8.98
2.7%
Not planned
17 Jun 2024
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold at will
$20.80K 2,315 at 8.99
1.6%
Not planned
16 Feb 2024
Sold at will
$59.05K 3,751 at 15.74
2.3%
Not planned
16 Feb 2024
Ho Junlin GENERAL COUNSEL
Sold at will
$54.93K 3,489 at 15.74
1.6%
Not planned
16 Feb 2024
Qatanani Mo CHIEF SCIENTIFIC OFFICER
Sold at will
$39.55K 2,512 at 15.74
1.7%
Not planned
16 Jan 2024
Ho Junlin GENERAL COUNSEL
Sold at will
$66.68K 4,186 at 15.93
2.6%
Not planned
Showing 1–50 of 57. Page 1 of 2 Older →